Intrinsic Value

The intrinsic value of Novozymes A/S (NSIS B) under the Base Case is DKK per share. Compared with the current market price of 451.4 DKK, the stock appears .

The intrinsic value is the average of valuations using the DCF method and multiples.

Do our valuations actually work? See backtest results .

NSIS B Intrinsic Value

What one share is worth in the bear, base and bull cases.

Create a free account · No card needed

Do our valuations actually work? See backtest results .

Alert me when NSIS B is below its intrinsic value
Today Hidden ·
NSIS B Valuation History

Intrinsic value next to the price over the past 5 years.

Create a free account · No card needed

Alternatives to NSIS B

Fundamental Analysis

What Novozymes A/S Does

Chemicals Materials

Novozymes A/S, a beacon of innovation in biotechnology, operates at the intricate intersection of science and sustainability. Born from the storied roots of Novo Nordisk in 2000, this Danish company has carved out a niche in the enzyme and microbial sector. Novozymes’ core competency lies in its ability to harness the power of natural organisms, using them to drive forward industrial solutions that are not only efficient but also eco-friendly.

Headquarters
Denmark DK
Employees
6 184
IPO date
May 27, 1905
Read the full company overview
View Company Overview
Financials
Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Continue NSIS B Research

Decided on Novozymes A/S? Get an email when NSIS B reaches the price you’d buy at. Free with an account.

What is the Intrinsic Value of one NSIS B stock?

The intrinsic value for Novozymes A/S (NSIS B) under the Base Case is DKK.

Is NSIS B stock undervalued or overvalued?

Compared with the current market price of 451.4 DKK, the stock appears .

How reliable are our estimates? See how past valuations played out
Back to Top